Table 2.
Fertility and preconception screening for couples completing IVF assessment.
| Male affected | Female affected | p-value | |
|---|---|---|---|
| n (%) | n (%) | ||
| Couples completing IVF assessment (n = 78) | 34 | 44 | |
| Fertility assessment | |||
| No subfertility or infertility | 24 (70.6) | 34 (77.3) | |
| Subfertility or infertility | 10 (29.4) | 10 (22.7) | |
| Female factor sub- or infertility (yes, %) | 3 (8.8) | 6 (13.6) | 0.72 |
| Male factor sub- or infertility* (yes, %) | 7 (20.6) | 3 (6.8) | 0.09 |
| Primary sub- or infertility (yes,%) | 0 (0.0) | 1 (2.3) | |
| Cardiovascular evaluation in women with NF1 (n = 44) | |||
| Cardiac evaluation performed | n.a. | 29 (65.9) | |
| No abnormalities documented | 19 (65.5) | ||
| Abnormalities documented | 5 (17.2) | ||
| Result missing | 5 (17.2) | ||
| No cardiac evaluation performed | n.a. | 15 (34.1) | |
IVF in vitro fertilization, NF1 Neurofibromatosis type 1, n.a. not applicable.
*Oligo- and/or asthenozoo- and/or teratozoospermia necessitating intrauterine insemination (IUI) or intracytoplasmic sperm injection (ICSI).